Camelia S. Stancu is a biochemist (Ph.D. from 2006), working in the Lipidomics Department of Institute of Cellular Biology and Pathology “Nicolae Simionescu”, Bucharest, in the field of lipoprotein metabolism, being interested about their composition and biosynthesis in the liver and small intestine. She paid special attention to the study of modified lipoproteins and their effects on the cells of the arterial wall. She developed animal models and cell cultures dedicated to study the lipoproteins' metabolism. Anti-atherosclerotic therapies based on bioactive compounds, pharmacologic drugs and epigenetic approaches are another domain of interest for her research. She is a member of the Romanian Society for Cell Biology, European Atherosclerosis Society and European Lipoprotein Club.